Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-69.52	173.25	-568.44
Graham Fair Price	-37.04	34.35	54.55
PEG	-51.94	-1.12	2.32
Price/Book	8.69	4.54	4.17
Price/Cash Flow	85.89	-41.82	-296.37
Prices/Earnings	163.77	66.75	25.31
Price/Sales	9.06	18.93	17.36
Price/FCF	85.89	-41.82	-296.37
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-89.82	0.07	0.70
Operating Margin	-40.30	0.07	0.12
ROA	-60.04	< 0.005	0.01
ROE	0.04	0.02	-58.79
ROIC	< 0.005	0.06	488.42
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.06	-98.85
Dividends QOQ	< 0.005	0.00	inf
EBIT QOQ	-0.52	-0.42	19.48
EPS QOQ	0.11	-0.60	448.87
FCF QOQ	-2.61	-6.56	-151.45
Revenue QOQ	0.03	-0.02	-34.60
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	25.47	8.71	-65.81
Days Sales Outstanding (DSO)	33.59	35.89	6.85
Inventory Turnover	3.53	10.34	192.49
Debt/Capitalization	0.58	0.58	0.84
Quick Ratio	1.03	0.54	-47.97
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	56.63	55.55	-1.92
Cash	6.95	2.89	-58.42
Capex	-3.78	-9.74	-157.80
Free Cash Flow	-0.80	-6.03	-655.56
Revenue	13.62	13.31	-2.25
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.24	0.68	-45.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-131.17	39.74	-69.70
Naive Interpretation	Member

06 - Financial Health · Bad

Rating